Focus on the BIG picture.
Thursday, Nov 05, 2026
Outside the box.
Food and Drug Administration Approves Advanced Biologics Treatment for Rare Genetic Disorder Developed by American Biotech Firm
The Food and Drug Administration granted formal commercial approval to a novel gene therapy treatment developed by a Massachusetts-based biotechnology company, providing a breakthrough therapeutic option for patients suffering from a severe hereditary neurological condition.